Testing for Cyclospora is not routinely done in most U.S. laboratories, even when stool specimens are tested for parasites; health-care providers must specifically request testing for Cyclospora when indicated. The preferred treatment for cyclosporiasis is trimethoprim-sulfamethoxazole; to date, no reliably effective alternative treatments have been identified (1, 3) . Cyclospora is not spread from person to person because excreted oocysts require several days to weeks outside the host to become infectious. Previous outbreaks in the United States have been associated with fruits (i.e., raspberries [2] ) and raw vegetables (i.e., mesclun lettuce, basil, and snow peas [3] ).
As of July 26, nearly all of Iowa's 135 reported cases of cyclosporiasis had been diagnosed by testing at the state's public health laboratory, the State Hygienic Laboratory (SHL) (Figure) . The two initial cases, reported in the June 28 issue of EPI Update, were diagnosed by a laboratorian at SHL who identified possible Cyclospora oocysts on microscopic examination of fresh stool and confirmed this diagnosis using a modified acid-fast stain technique. In June at SHL, before electronic messaging was used and media attention was attracted, 271 stool tests for ova and parasites were requested but none specifically for Cyclospora. In contrast, during the first 23 days of July, requests for general ova and parasite stool tests had increased to 762, and specific Cyclospora testing was requested on 1,460 specimens.
In addition to case ascertainment, increased attention by the news media and health department notifications led to improved diagnosis and treatment. For example, one patient with severe vomiting and diarrhea was discharged without a diagnosis after a 5-day hospital stay and extensive laboratory testing, only to relapse days later. After reading the EPI Update Alert, the patient's health-care provider ordered Cyclospora testing on the patient, and the result was positive. The patient was treated with trimethoprim-sulfamethoxazole, and the symptoms resolved.
The use of electronic messaging and media attention in the early stages of this outbreak investigation provided public health agencies a unique opportunity to increase testing for this uncommon disease, which might not otherwise have been considered by health-care providers or their patients. After diagnosis and case reporting, patients provided IDPH with valuable information on their potential exposures to Cyclospora, increasing the power of statistical analyses and the likelihood of finding the source of the infection. The Cyclospora outbreak investigation is ongoing. 
